Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality
- PMID: 30110591
- PMCID: PMC6165582
- DOI: 10.1056/NEJMoa1803626
Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality
Abstract
Background: Whether weight gain after smoking cessation attenuates the health benefits of quitting is unclear.
Methods: In three cohort studies involving men and women in the United States, we identified those who had reported quitting smoking and we prospectively assessed changes in smoking status and body weight. We estimated risks of type 2 diabetes, death from cardiovascular disease, and death from any cause among those who had reported quitting smoking, according to weight changes after smoking cessation.
Results: The risk of type 2 diabetes was higher among recent quitters (2 to 6 years since smoking cessation) than among current smokers (hazard ratio, 1.22; 95% confidence interval [CI], 1.12 to 1.32). The risk peaked 5 to 7 years after quitting and then gradually decreased. The temporary increase in the risk of type 2 diabetes was directly proportional to weight gain, and the risk was not increased among quitters without weight gain (P<0.001 for interaction). In contrast, quitters did not have a temporary increase in mortality, regardless of weight change after quitting. As compared with current smokers, the hazard ratios for death from cardiovascular disease were 0.69 (95% CI, 0.54 to 0.88) among recent quitters without weight gain, 0.47 (95% CI, 0.35 to 0.63) among those with weight gain of 0.1 to 5.0 kg, 0.25 (95% CI, 0.15 to 0.42) among those with weight gain of 5.1 to 10.0 kg, 0.33 (95% CI, 0.18 to 0.60) among those with weight gain of more than 10.0 kg, and 0.50 (95% CI, 0.46 to 0.55) among longer-term quitters (>6 years since smoking cessation). Similar associations were observed for death from any cause.
Conclusions: Smoking cessation that was accompanied by substantial weight gain was associated with an increased short-term risk of type 2 diabetes but did not mitigate the benefits of quitting smoking on reducing cardiovascular and all-cause mortality. (Funded by the National Institutes of Health.).
Figures
Comment in
-
Heavier but Healthier - Diabetes and Smoking Cessation.N Engl J Med. 2018 Aug 16;379(7):684-685. doi: 10.1056/NEJMe1809004. N Engl J Med. 2018. PMID: 30110593 No abstract available.
-
Nach Rauchstopp etwas dicker? Egal!MMW Fortschr Med. 2018 Nov;160(19):34. doi: 10.1007/s15006-018-1078-8. MMW Fortschr Med. 2018. PMID: 30406539 Review. German. No abstract available.
-
Smoking and Other Risk Factors in Type 2 Diabetes.N Engl J Med. 2018 Dec 27;379(26):2572-2573. doi: 10.1056/NEJMc1812842. N Engl J Med. 2018. PMID: 30586511 No abstract available.
-
Smoking and Other Risk Factors in Type 2 Diabetes.N Engl J Med. 2018 Dec 27;379(26):2573. doi: 10.1056/NEJMc1812842. N Engl J Med. 2018. PMID: 30586512 No abstract available.
Similar articles
-
Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study.Lancet Diabetes Endocrinol. 2020 Feb;8(2):125-133. doi: 10.1016/S2213-8587(19)30413-9. Epub 2020 Jan 7. Lancet Diabetes Endocrinol. 2020. PMID: 31924561 Free PMC article.
-
Weight Gain After Smoking Cessation and Risk of Major Chronic Diseases and Mortality.JAMA Netw Open. 2021 Apr 1;4(4):e217044. doi: 10.1001/jamanetworkopen.2021.7044. JAMA Netw Open. 2021. PMID: 33904915 Free PMC article.
-
Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes.JAMA. 2013 Mar 13;309(10):1014-21. doi: 10.1001/jama.2013.1644. JAMA. 2013. PMID: 23483176 Free PMC article.
-
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005353. doi: 10.1002/14651858.CD005353.pub3. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2011 Mar 16;(3):CD005353. doi: 10.1002/14651858.CD005353.pub4. PMID: 17943852 Updated. Review.
-
Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis.Lancet Diabetes Endocrinol. 2015 Dec;3(12):958-67. doi: 10.1016/S2213-8587(15)00316-2. Epub 2015 Sep 18. Lancet Diabetes Endocrinol. 2015. PMID: 26388413 Free PMC article. Review.
Cited by
-
Smoking cessation and mortality risk reduction in older adults with long-term smoking history.BMC Public Health. 2024 Oct 14;24(1):2821. doi: 10.1186/s12889-024-20270-w. BMC Public Health. 2024. PMID: 39402477 Free PMC article.
-
Metabolic Changes Following Smoking Cessation in Patients with Type 2 Diabetes Mellitus.Biomedicines. 2024 Aug 17;12(8):1882. doi: 10.3390/biomedicines12081882. Biomedicines. 2024. PMID: 39200346 Free PMC article.
-
Risk of incident type 2 diabetes in male NAFLD and NAFLD-free smokers: a 7-year post-cessation study.Diabetol Metab Syndr. 2024 Aug 8;16(1):192. doi: 10.1186/s13098-024-01435-4. Diabetol Metab Syndr. 2024. PMID: 39118126 Free PMC article.
-
Longitudinal Analysis of Diabetes Mellitus Risk: Smoking Status and Smoking Cessation.J Clin Med. 2024 Jul 4;13(13):3927. doi: 10.3390/jcm13133927. J Clin Med. 2024. PMID: 38999492 Free PMC article.
-
Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.Physiol Behav. 2024 Jul 1;281:114565. doi: 10.1016/j.physbeh.2024.114565. Epub 2024 Apr 23. Physiol Behav. 2024. PMID: 38663460 Free PMC article. Review.
References
-
- Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341–50. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials